Andrew Moses Lee, MD, PhD

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Andrew Moses Lee, MD, PhD sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 2 currently recruiting upper half by trial count

Andrew Moses Lee, MD, PhD: 2 sponsored US clinical trials, 2 recruiting.

Andrew Moses Lee, MD, PhD sponsors 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Obsessive - Compulsive Disorder, with 2 trials.

Mid-pack sponsor footprint

Andrew Moses Lee, MD, PhD is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the Andrew Moses Lee, MD, PhD pipeline

2 recruiting of 2 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Obsessive - Compulsive Disorder (2 trials), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Andrew Moses Lee, MD, PhD: open-pipeline peers nationwide

Peers matched on 2 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Andrew Moses Lee, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Andrew Moses Lee, MD, PhD1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Andrew Moses Lee, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Andrew Moses Lee, MD, PhD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this Andrew Moses Lee, MD, PhD page

2 registered trials is a research-attention snapshot, not an endorsement of Andrew Moses Lee, MD, PhD or any single study.

  • 2 of Andrew Moses Lee, MD, PhD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obsessive - Compulsive Disorder is the condition Andrew Moses Lee, MD, PhD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obsessive - Compulsive Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Andrew Moses Lee, MD, PhD pipeline card: 2 registered trials from official public datasets.Report a data error.